In our LiveTalk series, Being Patient spoke with Jason Ulrich, associate professor of neurology at Washington University in St. Louis, about the complex relationship between…
Researchers found that an experimental drug safely reduced Alzheimer’s pathology and improved the cognition in elderly squirrel monkeys. The team now plans to test…
New research takes one of the most widespread and fundamental theories about what causes Alzheimer’s and turns it on its head: Now some scientists…
In conversation with Being Patient leading up to the 2021 NIH Alzheimer’s Research Summit, University of Michigan assistant professor of neurology Dr. Lisa McGinley…
What if we think of Alzheimer’s not as one disease, but three separate ones, with overlapping symptoms? Researchers behind a new study say Alzheimer’s…
Shedding further light on the mystery of Alzheimer’s pathology, a new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…